World's first bedside genetic test developed | ummid.com

World's first bedside genetic test developed | ummid.com
This revolutionary technology allows doctors to rapidly identify patients with a genetic variant known as CYP2C19. Cardiac stent patients with this variant have chances of reacting poorly to standard anti-platelet therapy with Plavix® (clopidogrel).